chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Acne, Rash
Clinical narrative: big wild bright red rash on both cheeks with pimples; big wild bright red rash on both cheeks with pimples; This is a spontaneous report from a contactable consumer (patient).  A 69-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 10Mar2021 as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on unspecified date, single 1, dose for COVID-19 immunization. On unspecified date the patient experienced big wild bright red rash on both cheeks with pimples. reporter stated that it was starting to become a little less red than a few minutes ago and seems to be resolving but she did not read in any of our literature regarding a rash being a side effect but she read that Moderna had this type of side effect. The outcome of the events was unknown.  No follow-up attempts are possible. Information about Lot/Batch number cannot be obtained.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Chills, Dizziness, Hypersensitivity
Clinical narrative: allergic reaction; chills; dizziness; weakness; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received BNT162b2 (Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number and Expiration date was not reported) via an unspecified route of administration on 07Mar2021 as dose 1, single for COVID-19 immunisation. The patient medical history was not reported. There were no concomitant medications. On 08Mar2021, after 24 hours of the vaccination, patient experienced chills, dizziness and weakness. Patient stated that he thinks that he had an allergic reaction. Patient was going to contact his primary care physician. Patient stated that two days later the symptoms had disappeared. The outcome of all the events was recovered on 10Mar2021.   No follow-up attempts are possible; information about batch/ lot number cannot be obtained.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Dizziness
Clinical narrative: allergic reaction; chills; dizziness; weakness; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received BNT162b2 (Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number and Expiration date was not reported) via an unspecified route of administration on 07Mar2021 as dose 1, single for COVID-19 immunisation. The patient medical history was not reported. There were no concomitant medications. On 08Mar2021, after 24 hours of the vaccination, patient experienced chills, dizziness and weakness. Patient stated that he thinks that he had an allergic reaction. Patient was going to contact his primary care physician. Patient stated that two days later the symptoms had disappeared. The outcome of all the events was recovered on 10Mar2021.   No follow-up attempts are possible; information about batch/ lot number cannot be obtained.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Chills, Headache, Pain, Pain in extremity
Clinical narrative: fever; chills; headache; sleepy; severe body ache; sever left arm pain after an hour of vaccine taken; severe back pain; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 43-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine, Solution for injection), dose 1 via an unspecified route of administration, administered in arm left on 10Mar2021 12:45 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation (at the age of 43-year-old).  Medical history included Diabetes type 2, fatty liver and asthma from an unknown date and unknown if ongoing. Concomitant medication(s) included metformin (METFORMIN) taken for an unspecified indication, start and stop date were not reported; celecoxib (CELEXA [CELECOXIB]) taken for an unspecified indication, start and stop date were not reported; atorvastatin calcium (LIPITOR) taken for an unspecified indication, start and stop date were not reported; omeprazole (PROTONIX [OMEPRAZOLE]) taken for an unspecified indication, start and stop date were not reported; loratadine (ALLERTIN) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the covid 19 vaccine. The patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The patient had no known allergies. On 10Mar2021 01:45 PM, the patient experienced sever left arm pain after an hour of vaccine taken following severe back pain. On next day 11Mar2021, the patient experienced fever, chills, headache, sleepy and severe body ache. The patient not received treatment. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Somnolence
Clinical narrative: fever; chills; headache; sleepy; severe body ache; sever left arm pain after an hour of vaccine taken; severe back pain; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 43-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine, Solution for injection), dose 1 via an unspecified route of administration, administered in arm left on 10Mar2021 12:45 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation (at the age of 43-year-old).  Medical history included Diabetes type 2, fatty liver and asthma from an unknown date and unknown if ongoing. Concomitant medication(s) included metformin (METFORMIN) taken for an unspecified indication, start and stop date were not reported; celecoxib (CELEXA [CELECOXIB]) taken for an unspecified indication, start and stop date were not reported; atorvastatin calcium (LIPITOR) taken for an unspecified indication, start and stop date were not reported; omeprazole (PROTONIX [OMEPRAZOLE]) taken for an unspecified indication, start and stop date were not reported; loratadine (ALLERTIN) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the covid 19 vaccine. The patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The patient had no known allergies. On 10Mar2021 01:45 PM, the patient experienced sever left arm pain after an hour of vaccine taken following severe back pain. On next day 11Mar2021, the patient experienced fever, chills, headache, sleepy and severe body ache. The patient not received treatment. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on neck and both wrists; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 72-year-old (non-pregnant) female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN5318) via an unspecified route of administration, administered in arm left on 18Feb2021 14:45 (at the age of 72-year-old) at dose 2, single for covid-19 immunisation. Medical history Hashimoto thyroiditis, Blepharitis. Patient had no known allergies. Patient did not have other vaccine in four weeks. Patient did not have covid prior vaccination. Patient did not tested for covid post vaccination. Concomitant medications included levothyroxine (LEVOTHYROXINE); clonazepam (CLONAZEPAM); doxycycline (DOXYCYCLINE) taken for an unspecified indication, start and stop date were not reported (other medications in two weeks). Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL3302) via an unspecified route of administration, administered in arm left on 28Jan2021 14:45 (at the age of 72-year-old) at dose 1, single for covid-19 immunisation. On 04Mar2021 the patient experienced rash on neck and both wrists. Adverse event resulted in doctor or other healthcare professional office/clinic visit. Patient did not received treatment for the adverse event. Outcome of the event was not resolved.  No follow-up attempts are possible. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pruritus, Eye swelling, Ocular hyperaemia
Clinical narrative: Both eyes itchy, red, swollen, particularly my right eye; Both eyes itchy and red eyes; Both eyes red; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Batch/Lot number, Expiration date was not provided) via an unspecified route of administration in the left arm, on 10Mar2021 (age at vaccination 41-years) 10:30 as dose 2, single for covid-19 immunization. Patient medical history and concomitant medications were not reported. Historical vaccine included bnt162b2 (BNT162B2, Batch/Lot number, Expiration date was not provided), dose 1 (on 16Feb2021 at 12:30 in Left arm as dose 1, single for covid-19 immunization. Patient was not pregnant at the time of vaccination. on 11Mar2021 11:00 the patient experienced both eyes itchy, red, swollen, particularly right eye. The patient did not receive any treatment. The outcome of events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash spread to back & shoulders; Rash spread to chest; rash appeared on forearms; This is a spontaneous report from a contactable consumer (patient) reported for self. A 67-years-old female non- pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EL9264), dose 2 via an unspecified route of administration, administered in Arm Left on 20Feb2021 at 14:30 (at the age of 67-years-old) as a DOSE 2, SINGLE for covid-19 immunisation at Public Health Clinic. The patient medical history included hypertension (High blood pressure), hypothyroidism (hypothyroid) and obesity (obese) all from an unknown date and unknown if ongoing. Concomitant medications received in two weeks included lisinopril (LISINOPRIL), levothyroxine, liothyronine (NP THYROID), berberine (BERBERINE) and glycerine monolaurate, inosine (MONOLAURIN [GLYCERINE MONOLAURATE;INOSINE]) all were taken for an unspecified indication, start and stop date were not reported. The patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EN5318), dose 1 via an unspecified route of administration, administered in Arm Left on 30Jan2021 at 02:00 PM (at the age of 67-years-old) as a DOSE 1, SINGLE for covid-19 immunisation. Patient had no Known allergies. The patient did not have COVID prior vaccination and was not tested for covid post vaccination. The patient experienced rash appeared on forearms on 04Mar2021, rash spread to chest on 10Mar2021 and rash spread to back & shoulders on 11Mar2021, does not itch. No treatment was received for the event. Outcome of all the events were not resolved.  No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Hypoaesthesia, Hypoaesthesia oral, Nausea
Clinical narrative: 101.8 fever; significant body ache; headahce; nausea; lightheaded/vertigo; lightheaded/vertigo; numbness in L cheek and tongue; numbness in L cheek and tongue; This is a spontaneous report from a non-contactable other-HCP. This Other-HCP reporting for a 35-years-old female patient.  A 35-years-old non-pregnant female patient (not pregnant at the time of vaccination) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in left arm on 09Mar2021 09:45 as dose 2, single (at the age of 35-years-old) for covid-19 immunisation. The patient medical history included allergy to soy, corn, dust, cats. The patient concomitant medications included fish oil (OMEGA 3 [FISH OIL]) taken for an unspecified indication, start and stop date were not reported and probiotics (PROBIOTICS) taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration, administered in Left arm on 19Feb2021 at 10:00 (at the age of 35-years-old) as dose 1, single for covid-19 immunisation. The patient had not taken other vaccine in four weeks. The patient was not diagnosed with covid-19 prior to vaccination. Since vaccination, the patient has not been tested for covid-19. On 09Mar2021 at 13:00, the patient experienced 101.8 fever, significant body ache, headache, nausea, lightheaded/vertigo and numbness in l cheek and tongue. The patient did not receive any treatment for the events. The outcome of the events were recovering.  No follow-up attempts are possible. No further information is obtained.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Vertigo
Clinical narrative: 101.8 fever; significant body ache; headahce; nausea; lightheaded/vertigo; lightheaded/vertigo; numbness in L cheek and tongue; numbness in L cheek and tongue; This is a spontaneous report from a non-contactable other-HCP. This Other-HCP reporting for a 35-years-old female patient.  A 35-years-old non-pregnant female patient (not pregnant at the time of vaccination) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in left arm on 09Mar2021 09:45 as dose 2, single (at the age of 35-years-old) for covid-19 immunisation. The patient medical history included allergy to soy, corn, dust, cats. The patient concomitant medications included fish oil (OMEGA 3 [FISH OIL]) taken for an unspecified indication, start and stop date were not reported and probiotics (PROBIOTICS) taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration, administered in Left arm on 19Feb2021 at 10:00 (at the age of 35-years-old) as dose 1, single for covid-19 immunisation. The patient had not taken other vaccine in four weeks. The patient was not diagnosed with covid-19 prior to vaccination. Since vaccination, the patient has not been tested for covid-19. On 09Mar2021 at 13:00, the patient experienced 101.8 fever, significant body ache, headache, nausea, lightheaded/vertigo and numbness in l cheek and tongue. The patient did not receive any treatment for the events. The outcome of the events were recovering.  No follow-up attempts are possible. No further information is obtained.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Erythema, Feeling hot, Sleep disorder, Swelling
Clinical narrative: extreme joint pain at times; heat; swelling; redness; can't sleep; Joint pain few in right hip and right thumb; This is a spontaneous report from a contactable consumer (patient). A 82-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date (age at vaccination: 82 years), as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient stated she has been experiencing "bizarre" symptoms after getting the first dose of the Pfizer-BioNTech COVID-19 vaccine, since she has "never experienced this before". She specified she has "extreme joint pain at times" then the "swelling", the "redness" and the "heat" were "gone". She explained these joint pains were "continuous but not at the same level of discomfort". She listed the following different joint pain locations and mentioned different intensities for some at "Shoulder", which get "sore enough" that she "can't sleep", at "Few in [her] right hip", at "Right thumb", "One time [her] left foot had a reaction but is now back to normal", then " [her] right foot", and other area at a milder" intensity. She asked if her symptoms were reported as a side effect of the vaccine. The patient asked if she should get the second dose of the Pfizer-BioNTech COVID-19 vaccine given her reaction to the first. Outcome of the event extreme joint pain at times was not recovered, can't sleep and joint pain few in right hip and right thumb was unknown, and for all other events, it was recovered on an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Rash, Rash pruritic
Clinical narrative: rash that came on "all at one time" and seems to be anywhere, from: "under his arms, down his torso, on his stomach, down to his groin, and down his legs"; The rash goes from itchy to burning then progresses to pain; The rash goes from itchy to burning then progresses to pain; This is a spontaneous report from a contactable consumer (patient wife) via medical information department.   A 70-year-old male patient received BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot/batch number and expiry date were not reported), via an unspecified route of administration, on 06Mar2021 (Saturday), as a dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 10Mar2021, 4 days later Wednesday the patient develop rash all at one time and seems to be anywhere his clothes touch him from under his arms, down his torso, not as noticeable on his stomach, down to his groin, and down his legs. The rash was incredibly itchy, randomly getting worse. The rash goes from itchy to burning then progresses to pain. The urgent care prescribed steroids and antihistamines, Benadryl and Pepcid- not enough to keep him comfortable but neither seem to be helping to keep him comfortable. No other changes to lifestyle and have not been going out in public. The reporter queried should he take his second dose of vaccine and what recommendation to treat patient rash. Outcome of the events were not recovered.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Erythema, Fatigue, Feeling hot
Clinical narrative: Redness; extreme pain; hot; hard size of a quarter at the injection site; fatigue; Diarrhea; fever; headaches; hot flash; chills; This is a spontaneous report from a contactable consumer. A 20-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: En6199) via an unspecified route of administration, administered in Arm Left on 06Mar2021 11:30 (age at vaccination 20-years-old) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medication were not reported. On 06Mar2021 11:30 AM, patient experienced Redness, extreme pain, hot, and hard size of a quarter at the injection site, fatigue, Diarrhea, fever, headaches, hot flash, chills. No treatment was received for events. Patient has not taken any other vaccine with in four weeks and other medication in two weeks was Prescribed medicines. Patient has no known allergies reported. Patient has stated that she had not been diagnosed with COVID -19 prior to vaccination and unknown if tested since the vaccination. Outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hot flush, Pain, Pyrexia, Vaccination site induration
Clinical narrative: Redness; extreme pain; hot; hard size of a quarter at the injection site; fatigue; Diarrhea; fever; headaches; hot flash; chills; This is a spontaneous report from a contactable consumer. A 20-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: En6199) via an unspecified route of administration, administered in Arm Left on 06Mar2021 11:30 (age at vaccination 20-years-old) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medication were not reported. On 06Mar2021 11:30 AM, patient experienced Redness, extreme pain, hot, and hard size of a quarter at the injection site, fatigue, Diarrhea, fever, headaches, hot flash, chills. No treatment was received for events. Patient has not taken any other vaccine with in four weeks and other medication in two weeks was Prescribed medicines. Patient has no known allergies reported. Patient has stated that she had not been diagnosed with COVID -19 prior to vaccination and unknown if tested since the vaccination. Outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash pruritic, Rash vesicular, Swelling of eyelid
Clinical narrative: Blistered, itchy, raised rash to both forearms; Blistered, itchy, raised rash to both forearms; generalized body itching including scalp, face, neck, trunk, extremities; Eyelids moderately swollen; This is a spontaneous report from a contactable other hcp (Patient). A 55-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Lot Number: EL3248) via an unspecified route of administration (Age at vaccination 55-year) in left arm on 29Jan2021 at 11:00 AM as dose 2, single for COVID-19 immunization. Medical history included hypothyroidism, calcium citrate kidney stones, Mastcell Activation Disorder/Mastocytosis, Elevated Tryptase level, all from an unknown date and unknown if ongoing; history of allergic reactions to medications, On Montelukast and Levocetirizine allergy medications for Elevated Tryptase level vs. Mastcell Activation Disorder/Mastocytosis, hypothyroidism, calcium citrate kidney stones. Concomitant medications included levothyroxine sodium (SYNTHROID); hydrochlorothiazide; amiloride hcl; potassium; taken in two weeks of COVID-19 vaccination, for an unspecified indication, start and stop date were not reported. Historical vaccine included first dose of BNT162B2 (lot Number: EK9231) administered in left arm on 07Jan2021 at 04:00 PM for COVID-19 immunization. The patient previously took Mobic, Hydrocodone, Codeine, and experienced allergies. Reported facility type vaccine was hospital. The patient received no COVID prior vaccination. The patient not tested COVID post vaccination. The patient received no other vaccine in four weeks. On 02Feb2021 the patient experienced blistered, itchy, raised rash to both forearms; generalized body itching including scalp, face, neck, trunk, extremities; eyelids moderately swollen. AE resulted in doctor or other healthcare professional office/clinic visit. The patient received no treatment for the adverse events. The clinical outcome of the events was resolving.   No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash erythematous, SARS-CoV-2 test
Clinical narrative: Covid arm Red raised rash; Itchy; This is a spontaneous report from a contactable other hcp (Patient). A 42-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Batch/Lot Number: Unknown, Expiration date: Unknown) via an unspecified route of administration (age at vaccination 42-year) in left arm on 08Mar2021 at 10:30 AM as dose 1, single for COVID-19 immunization. Medical history included autoimmune problems (since COVID), and COVID-19 (prior COVID vaccination), both from an unknown date and unknown if ongoing. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) taken in two weeks of COVID-19 vaccination, for an unspecified indication, start and stop date were not reported. The patient tested COVID post vaccination. The patient received no other vaccine in four weeks. The patient had no allergies reported. On 10Mar2021 the patient experienced COVID arm red raised rash, itchy. The patient underwent lab tests and procedures on 11Mar2021 which included SARS-COV-2 test: unknown results. The patient received no treatment for the adverse events. The clinical outcome of the events was not resolved.  No follow-up attempts are possible; information about batch/ lot number cannot be obtained.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Joint stiffness, Pain in extremity
Clinical narrative: Arm sore; Joints (hips, knees & back) stiff and achy; Joints (hips, knees & back) stiff and achy; This is a spontaneous report from a non-contactable consumer (patient). A 71-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; expiry date-unknown; Batch/Lot Number: EN6202), via an unspecified route of administration, administered in Arm Left on 10Mar2021 10:30 (at the age of 71-year-old) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included asthma, high blood pressure and known allergies: Certain fruits. Concomitant medications included montelukast 10 mg; enalapril maleate 20mg 2x daily Am. No covid prior to vaccination. The patient experienced arm sore, joints (hips, knees & back) stiff and achy on 10Mar2021 18:30. No covid tested post vaccination. It was reported that Arm was still sore on the 2nd day. Joints (hips, knees & back) stiff and achy which started 6 or 7pm yesterday evening and continue to be achy today. No treatment received. The clinical outcome of the events was not recovered.  No follow up attempts are possible. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Pain, Pyrexia
Clinical narrative: Body aches; 101.7 temp; Fatigue; This is a spontaneous report from a contactable consumer (patient). A 64-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 08Mar2021 12:30 (Batch/Lot number and expiry date not reported) as DOSE 2, SINGLE for COVID-19 immunization. Medical history was not reported. The patient was not pregnant at the time of vaccination. The patient was vaccinated at a public health clinic/veterans administration facility. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient had no known allergies. Concomitant medications included sertraline taken for an unspecified indication, start and stop date were not reported; lisinopril taken for an unspecified indication, start and stop date were not reported. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route, left arm, on 15Feb2021 12:00 (at the age of 63 years) as dose 1, single for COVID-19 immunization. The patient experienced body aches on 09Mar2021 12:00 with outcome of recovered on Mar2021, 101.7 temp on 09Mar2021 12:00 with outcome of recovered on Mar2021, and fatigue on 09Mar2021 12:00 with outcome of recovered on Mar2021. The patient underwent lab tests and procedures which included body temperature: 101.7 on an unspecified date. No therapeutic measures were taken as a result of the events. The events were assessed as non-serious.  No follow-up attempts are possible; information about batch/ lot number cannot be obtained.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pain in extremity, Peripheral swelling, Pyrexia
Clinical narrative: Chills; Slight fever; very sore with swelling on the left arm; aching of the upper body; very sore with swelling on the left arm; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 63-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Batch/Lot Number: EN6204), via an unspecified route of administration, administered in Arm Left on 10Mar2021 11:15 (at the age of 63-years-old) as dose 1, single for COVID-19 immunisation. Medical history included malaria (over 30 years ago) from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Patient was unaware of allergic reactions. It was reported that she was not a pregnant at the time of vaccination. She did not take any other vaccine in four weeks prior COVID -19 vaccine. She was not diagnosed with COVID prior vaccination and not tested with COVID post vaccination. On 11Mar2021 09:30 AM, the patient experienced chills, slight fever, very sore with swelling on the left arm and aching of the upper body. No therapeutic measures were taken. The outcome of events was recovering.  No follow up attempts are possible. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Injection site pain, Pyrexia
Clinical narrative: painful injection site; severe chills; fever; fatigue; This is a spontaneous report from a contactable consumer (patient). A 65-year-old non pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: not reported), via an unspecified route of administration, administration on left arm on 15Feb2021 at 08:15 (at the age of 65-years-old) as single dose for covid-19 immunization. The patient was not pregnant at the time of vaccination. Medical history included COVID-19 on 10Jan2021 and was very sick for 12 days. The patient concomitant medications included acetaminophen. Patient had no known allergies Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had not been tested for COVID-19 Since the vaccination. On 15Feb2021, the patient experienced painful injection site, severe chills, fever and fatigue. It was reported that, because she had COVID and she was sick, she decided to get the vaccine as soon as possible. She had first vaccine on 15Feb2021 and about 8 hours after vaccine began to have very painful injection site, as well as severe chills, fever and fatigue which resolved in 48 hours. Patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6203), via an unspecified route of administration, administration on left arm on 08Mar2021 at 08:15 (at the age of 65-year-old) as single dose for COVID-19 immunization and experienced adverse events. The outcome of the events was recovered on an unspecified date in Feb2021.   No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021273380 Same reporter,patient,product/ 2nd dose
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Rash, Rash erythematous, Swelling
Clinical narrative: Rash with swelling; warm to the touch; red with a distinct line of rash; Rash with swelling; This is a spontaneous report from a contactable consumer (patient herself). A 29-years-old female patient non- pregnant received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EN6205), dose 1 via an unspecified route of administration, administered in Arm Left on 04Mar2021 at 14:30 (at the age of 29-years-old) as a DOSE 1, SINGLE for covid-19 immunisation at Public Health Clinic/Veterans Administration facility. The patient medical history included herpes virus infection and asthma both from an unknown date and unknown if ongoing. Other medications in two weeks were Birth control medications. The patient did not have any known allergies. Other vaccine in four weeks were none. Patient did not have covid prior vaccination was not tested for covid post vaccination. On 11Mar2021 at 20:00, patient experienced rash with swelling, warm to the touch and red with a distinct line of rash. No treatment was received for the events. Outcome of all the events were not recovered.  No follow-up attempt is possible. No further information expected.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Fatigue, Flushing, Palpitations
Clinical narrative: dizziness; restricted breathing; heart palpitations along with occasional flush feeling; heart palpitations along with occasional flush feeling; very fatigued; This is a spontaneous report from a contactable consumer (patient). A 49-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 10Mar2021 at 10:45 (at the age of 49-years-old) as dose 1, single for COVID-19 immunization. Medical history included blood cholesterol increased from an unknown date and unknown if ongoing. Concomitant medication(s) included acetylsalicylic acid (ASPIRIN 81), pravastatin and tadalafil taken for an unspecified indication, start and stop date were not reported. The patient previously took lipitor [atorvastatin] and experienced drug hypersensitivity. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Patient reported that shortly after receiving the shot, 10 Mar2021 11:00, patient experienced dizziness, restricted breathing and heart palpitations along with occasional flush feeling also very fatigued (10Mar2021) and that fatigue continued the next day (today, 11Mar2021). The patient did not receive any treatment. The clinical outcome for the events was recovering except not recovered for very fatigued.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Pain, Pyrexia
Clinical narrative: chills; fever/102.2 fever; head and body aches began around midnight; head and body aches began around midnight; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 67-year-old female patient received bnt162b2 (Comirnaty, Solution for injection, Batch/Lot number: EN6202, expiry date: not reported, Age at vaccination: 67-year-old) via an unspecified route of administration in Left arm on 05Mar2021 09:30 AM as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history was not reported. Concomitant medications included Synthroid, Singulair, Ambien. Historical vaccine included bnt162b2 for COVID-19 immunisation. On 05Mar2021 11:30 PM, patient experienced chills, fever, head and body aches. No other vaccine in four weeks. No treatment received for adverse event. No covid prior vaccination. No covid tested post vaccination. No known allergies. Lab test included Fever: 102.2 on 05Mar2021. The outcome of events was recovered.  No follow-up attempts are possible. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Fatigue, Myalgia, Pyrexia
Clinical narrative: joint pain; fatigue; low fever; diarrhea; slight runny nose; muscle pain; This is a Spontaneous report from a Contactable Pharmacist. This 62-year-old female Pharmacist reported for herself that:  A 62-year-old (non-pregnant) female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EL9267), via an unspecified route of administration, administered in Arm Left on 22Feb2021 13:15 (at the age of 62 years old) as SINGLE DOSE for covid-19 immunisation.  Medical history included myofascial pain (Myofascial pain syndrome) from an unknown date and unknown if ongoing, shoulder impingement (rotator cuff syndrome) from an unknown date and unknown if ongoing, atrial fibrillation from an unknown date and unknown if ongoing , spinal fusion surgery from an unknown date and unknown if ongoing. Concomitant medication(s) included Multaq (dronedarone hydrochloride) taken for an unspecified indication, start and stop date were not reported; Eliquis (Apixaban) taken for an unspecified indication, start and stop date were not reported; Protonix (Omeprazole) taken for an unspecified indication, start and stop date were not reported; Digoxin (Digoxin) taken for an unspecified indication, start and stop date were not reported; Biotin (Biotin) taken for an unspecified indication, start and stop date were not reported.  It was reported that no other vaccine administered in four weeks. Covid prior to vaccination was no. Covid tested post vaccination was yes. Patient had no known allergies. The patient experienced joint pain, fatigue, low fever, diarrhea, slight runny nose, muscle pain on 23Feb2021 23:00. The patient underwent lab tests and procedures which included Nasal Swab (sars-cov-2 antibody test negative): negative on 10Mar2021. Therapeutic measure were taken as unknown as a result of event. The outcome of events was not recovered.   No follow-up attempts are possible. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 antibody test negative
Clinical narrative: joint pain; fatigue; low fever; diarrhea; slight runny nose; muscle pain; This is a Spontaneous report from a Contactable Pharmacist. This 62-year-old female Pharmacist reported for herself that:  A 62-year-old (non-pregnant) female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EL9267), via an unspecified route of administration, administered in Arm Left on 22Feb2021 13:15 (at the age of 62 years old) as SINGLE DOSE for covid-19 immunisation.  Medical history included myofascial pain (Myofascial pain syndrome) from an unknown date and unknown if ongoing, shoulder impingement (rotator cuff syndrome) from an unknown date and unknown if ongoing, atrial fibrillation from an unknown date and unknown if ongoing , spinal fusion surgery from an unknown date and unknown if ongoing. Concomitant medication(s) included Multaq (dronedarone hydrochloride) taken for an unspecified indication, start and stop date were not reported; Eliquis (Apixaban) taken for an unspecified indication, start and stop date were not reported; Protonix (Omeprazole) taken for an unspecified indication, start and stop date were not reported; Digoxin (Digoxin) taken for an unspecified indication, start and stop date were not reported; Biotin (Biotin) taken for an unspecified indication, start and stop date were not reported.  It was reported that no other vaccine administered in four weeks. Covid prior to vaccination was no. Covid tested post vaccination was yes. Patient had no known allergies. The patient experienced joint pain, fatigue, low fever, diarrhea, slight runny nose, muscle pain on 23Feb2021 23:00. The patient underwent lab tests and procedures which included Nasal Swab (sars-cov-2 antibody test negative): negative on 10Mar2021. Therapeutic measure were taken as unknown as a result of event. The outcome of events was not recovered.   No follow-up attempts are possible. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Heart rate, Heart rate increased, Pain
Clinical narrative: Itching; Headaches; pain all over; chest feels like it was beating a little fast; Tired; This is a spontaneous report received from a contactable consumer (patient). A 65-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EN6206, Expiration date was not reported), via an unspecified route of administration in arm left (upper left arm) on 08Mar2021 at 11:15 (at the age of 65-year-old) as a dose 1, single for COVID-19 immunization. The patient's medical history included fibromyalgia, arthritis and acid reflux, known allergies: lactose, known allergies: penicillin and COVID-19. Past drug event included Cefaclor and experienced Known allergies: Cefaclor and Erythromycin and experienced Known allergies. The patient's concomitant medications in two weeks included lansoprazole (PREVACID), dexamethasone, tobramycin (TOBRAMYCIN AND DEXAMETHASONE OPHTHALMIC SUSPENSION), both were taken for an unspecified indication. It was reported that, the patient was not pregnant at time of vaccination. No other vaccine in four weeks. The patient was diagnosed with covid prior vaccination and covid tested post vaccination was reported as yes. On 08Mar2021 at 13:00, the patient experienced Itching, headaches, pain all over, chest feels like it was beating a little fast, tired. The events resulted in doctor or other healthcare professional office/clinic visit. Treatment medications included Benadryl, Tylenol. On an unspecified date, the patient underwent lab test and procedures which included COVID-19 test (SARS-CoV-2 test), resulted as unknown results and chest feels like it was beating a little fast (heart rate), resulted as increased on 08Mar2021. The outcome of the events was recovering.  No follow up attempts are possible. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, SARS-CoV-2 test
Clinical narrative: Itching; Headaches; pain all over; chest feels like it was beating a little fast; Tired; This is a spontaneous report received from a contactable consumer (patient). A 65-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EN6206, Expiration date was not reported), via an unspecified route of administration in arm left (upper left arm) on 08Mar2021 at 11:15 (at the age of 65-year-old) as a dose 1, single for COVID-19 immunization. The patient's medical history included fibromyalgia, arthritis and acid reflux, known allergies: lactose, known allergies: penicillin and COVID-19. Past drug event included Cefaclor and experienced Known allergies: Cefaclor and Erythromycin and experienced Known allergies. The patient's concomitant medications in two weeks included lansoprazole (PREVACID), dexamethasone, tobramycin (TOBRAMYCIN AND DEXAMETHASONE OPHTHALMIC SUSPENSION), both were taken for an unspecified indication. It was reported that, the patient was not pregnant at time of vaccination. No other vaccine in four weeks. The patient was diagnosed with covid prior vaccination and covid tested post vaccination was reported as yes. On 08Mar2021 at 13:00, the patient experienced Itching, headaches, pain all over, chest feels like it was beating a little fast, tired. The events resulted in doctor or other healthcare professional office/clinic visit. Treatment medications included Benadryl, Tylenol. On an unspecified date, the patient underwent lab test and procedures which included COVID-19 test (SARS-CoV-2 test), resulted as unknown results and chest feels like it was beating a little fast (heart rate), resulted as increased on 08Mar2021. The outcome of the events was recovering.  No follow up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chills, Cough, Dizziness
Clinical narrative: Cough; Shortness of breath (except at rest); Fever; Chills; Weakness; Tiredness; Pain in vaccinated arm; Red blotches/soreness on front of upper arm and shoulder; Red blotches/soreness on front of upper arm and shoulder; Red blotches/soreness on front of upper arm and shoulder; Dizziness; This is a spontaneous report from a contactable consumer (patient).  A 67-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number EN6203), via an unspecified route of administration, in Left arm on 07Mar2021 05:00 PM (at the of 67 years old) as dose 2, single for COVID-19 immunization. Medical history included cancer survivor with ongoing maintenance. Concomitant medications included trastuzumab (HERCEPTIN), carvedilol (CARVEDILOL), valsartan (VALSARTAN) taken in two weeks. Patient had no known allergies. Patient was not tested positive for COVID post vaccination and patient not had COVID prior vaccination. patient had not received any other vaccine in four weeks. Patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot number EL9266), via an unspecified route of administration, in Left arm on 14Feb2021 05:15 PM as dose 1, single for COVID-19 immunization. On 08Mar2021 07:00 AM the patient experienced Fever, chills, weakness, tiredness, pain in vaccinated arm with red blotches/soreness on front of upper arm and shoulder, cough, shortness of breath (except at rest), dizziness. Patient had not received any treatment for events. The outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Pain in extremity, Pyrexia, Rash macular
Clinical narrative: Cough; Shortness of breath (except at rest); Fever; Chills; Weakness; Tiredness; Pain in vaccinated arm; Red blotches/soreness on front of upper arm and shoulder; Red blotches/soreness on front of upper arm and shoulder; Red blotches/soreness on front of upper arm and shoulder; Dizziness; This is a spontaneous report from a contactable consumer (patient).  A 67-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number EN6203), via an unspecified route of administration, in Left arm on 07Mar2021 05:00 PM (at the of 67 years old) as dose 2, single for COVID-19 immunization. Medical history included cancer survivor with ongoing maintenance. Concomitant medications included trastuzumab (HERCEPTIN), carvedilol (CARVEDILOL), valsartan (VALSARTAN) taken in two weeks. Patient had no known allergies. Patient was not tested positive for COVID post vaccination and patient not had COVID prior vaccination. patient had not received any other vaccine in four weeks. Patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot number EL9266), via an unspecified route of administration, in Left arm on 14Feb2021 05:15 PM as dose 1, single for COVID-19 immunization. On 08Mar2021 07:00 AM the patient experienced Fever, chills, weakness, tiredness, pain in vaccinated arm with red blotches/soreness on front of upper arm and shoulder, cough, shortness of breath (except at rest), dizziness. Patient had not received any treatment for events. The outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.